[Effect of hyperosmolar solutions on mesenteric blood flow and in postoperative intestinal atonia].
D000818:Animals; D002302:Cardiac Output / Q000187:drug effects; D003911:Dextrans / Q000494:pharmacology / Q000627:therapeutic use; D004285:Dogs; D005632:Fructose / Q000627:therapeutic use; D005769:Gastrointestinal Motility / Q000187:drug effects*; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D006982:Hypertonic Solutions; D007263:Infusions, Parenteral; D007415:Intestinal Obstruction / Q000188:drug therapy*; D008353:Mannitol / Q000627:therapeutic use; D008643:Mesentery / Q000098:blood supply*; D008833:Microcirculation / Q000187:drug effects; D009129:Muscle Tonus / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009994:Osmolar Concentration; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy*; D012039:Regional Blood Flow / Q000187:drug effects; D012965:Sodium Chloride / Q000627:therapeutic use; D013012:Sorbitol / Q000627:therapeutic use
D003911:Dextrans; D006982:Hypertonic Solutions; D010952:Plasma Substitutes; D005632:Fructose; D008353:Mannitol; D012965:Sodium Chloride; D013012:Sorbitol; D005947:Glucose
Die Wirkung hyperosmolarer Lösungen auf die Mesenterialdurchblutung und bei postoperativer Darmatonie.